Abstract
Purpose: Proconvulsive and proepileptogenic effects of neuroleptics had been described a long ago. Based on the small number of studies it is estimated that patients treated with optimal therapeutic doses of commonly used neuroleptics significantly more frequently presented with transient EEG changes (7% of patients) in relation to the incidence of epileptic attacks (0.1–1.5%). The aim of our study was to verify epileptogenic impact of neuroleptic treatment in the group adolescent patients. Methods: The study included 19 adolescents with chronic neuroleptic therapy and optimal therapeutic doses. None of the patients experienced seizures before therapy. The average age of the patients was 16.5 yrs, the average therapy duration was 3 yrs. Results: 68% of the adolescents had nonspecific EEG findings. 32% had specific (bilateral epileptiform paroxysmal/nonparoxysmal) EEG changes. Half of them, with normal MRI, presented with seizures as a clinical correlate to the EEG changes (0.2% of the population). The greatest epileptogenic potential had olanzapine, chlorpromazine and haloperidol. Conclusion: In our experience, arising from this study, proepileptogenic and proconvulsive effects of neuroleptics were once again confirmed, particularly strong among adolescents, suggesting an important receptor hypersensitivity likely caused by endogenous and biological factors (age, hormonal status, the dynamic body mass, volume changes, etc).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.